Heba Effat

11PUBLICATIONS
14CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 25, 2026
Anti-Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells.

Esraa A Aidy, Elshaymaa I Elmongy, Abdullah A S Ahmed

|Feb 12, 2026
Correction: The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells.

Heba Effat, Motawa E El Houseini, Rehab S Abohashem

|Jan 26, 2026
Cyclophosphamide: Potential Hepatorenal Toxicity and the Possible Therapeutic Role of Mesenchymal Stem Cell-Derived Exosomes in Wistar Rats.

Ahmed N Abdallah, Heba Effat, Ahmed M Mousbah

|Oct 29, 2025
Isatin, a monoamine oxidase inhibitor, sensitizes resistant breast cancer cells to tamoxifen via MAO-A/HIF1α/MMPs modulation.

Fatma M Abdelwahed, Marwa A Ibrahim, Marwa Sharaky

|Sep 09, 2025
Rutin Alleviates Breast Cancer Resistance to Tamoxifen By Downregulating ABC Transporters, Inducing ROS Generation and Resetting Redox Status.

Heba Effat, Aliaa M Radwan, Marwa Sharaky

|Mar 10, 2025
Vitamin D promotes anticancer effects of low-concentration cisplatin-treated non-small cell lung cancer cells via inhibiting the JAK2/STAT3 and TGF-β/SMAD4 pathways.

Heba Effat, Rehab S Abohashem, Marwa Sharaky

Pageof 2

Frequent Collaborators

4 joint publications

Rehab S Abohashem

2 joint publications

Hanaa H Ahmed

2 joint publications

Hamed A Abosharaf

2 joint publications

Marwa Sharaky